Skip to content
value.today

Insitro, Inc.

Total raised
$143 M
1 round on record
Latest round
$143 M
Mar 2020
First round on record
Mar 2020
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Insitro, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2020$143 MNo. 1$50 to $250 million

Insitro, Inc.: Raise no. 1, Mar 2020

Investors in this round

26 investors had bought by the notice of May 27, 2020: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 3 investors are named for Insitro, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$143 M of $143 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Daphne Koller · Executive Officer, Director · Chief Executive Officer
  • Duane Valz · Executive Officer · General Counsel
  • Mary Rozenman · Executive Officer · Chief Financial Officer
  • Robert Nelsen · Director
  • Vijay Pande · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Duane Valz, General Counsel. Source: SEC Form D, newest notice filed May 27, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Insitro, Inc. chose not to state its revenue in its newest notice of a funding round (May 2020).

    SEC Form D · May 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · May 2020

That is all the official record says: Insitro, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

3 named in official filings. Open an investor to see everything it has backed.

Investors in Insitro, Inc.
InvestorKindAmountRoundRoleSource
BlackRock Health Sciences Term TrustFund or asset manager$7 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT
BlackRock Health Sciences Opportunities PortfolioFund or asset manager$4 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT
BlackRock Health Sciences TrustFund or asset manager$0 Mheldnot statedHolds shares (fund report, Jun 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 26 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Insitro, Inc.
NameRoleNamed in
Daphne KollerChief Executive OfficerMay 2020
Duane ValzGeneral CounselMay 2020
Mary RozenmanChief Financial OfficerMay 2020
Daphne KollerChief Executive OfficerMay 2020
Robert NelsenDirectorMay 2020
Vijay PandeDirectorMay 2020